PRLD Insider: 9,375 RSUs Vest; 3,355 Shares Withheld
Rhea-AI Filing Summary
Jane Huang, President and CMO of Prelude Therapeutics Inc (PRLD), reported transactions on 10/04/2025 showing the vesting and withholding related to restricted stock units (RSUs). 9,375 RSUs became vested (transaction code M), creating a contingent right to the same number of common shares; those RSUs increased her direct ownership before withholding to 90,272 shares. The company withheld 3,355 shares to satisfy tax obligations at a withholding price of $1.47, leaving 86,917 shares beneficially owned after the taxable disposition. The filing notes the RSUs were granted on 05/02/2022 and follow a vesting schedule that began with 1/4 vesting on 04/04/2023 and quarterly vesting of the remainder while employment continues. The report is signed by an attorney-in-fact on 10/07/2025.
Positive
- 9,375 RSUs vested on 10/04/2025, converting contingent awards into direct equity
- Beneficial ownership remains substantial at 86,917 shares after withholding, indicating continued insider stake
Negative
- 3,355 shares withheld to cover taxes at $1.47, reducing outstanding shares received by the reporting person
- Vesting contingent on continued service, so future vesting depends on employment continuity
Insights
Vesting reflects scheduled compensation delivery; withholding confirms tax settlement.
The reported 9,375 RSU vesting converts contingent equity into direct ownership, temporarily increasing beneficial holdings to 90,272 shares before tax withholding. The withheld 3,355 shares at $1.47 reduce net ownership to 86,917, matching a common practice to satisfy payroll/tax obligations without cash outlay.
This follows the grant on 05/02/2022 with initial 1/4 vesting on 04/04/2023 and quarterly vesting thereafter; continuation of employment is the stated vesting condition. Monitor upcoming quarterly vesting dates for further share delivery or withholding events within the next 12 months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 9,375 | $0.00 | -- |
| Exercise | Common Stock | 9,375 | $0.00 | -- |
| Tax Withholding | Common Stock | 3,355 | $1.47 | $5K |
Footnotes (1)
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock. Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs. The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date.
